Aug 17, 2026

  • Add News

Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisions

New rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has amended the Drugs Rules, 1945. This adds accountability for drug manufacturers and distributors operating in the country. The Licensing Authority can now debar entities from filing future applications. This amendment aims to deter misconduct and ensure reliable drug approval evidence.

RSS News
Economic times

0 thoughts on “Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisions

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies to ensure that we give you the best experience on our website. By continuing to browse our site we'll assume that you understand this. Learn more